The subject matter described herein relates to fluidizable beds and particularly to a fluidizable bed having the capability to laterally rotate an occupant of the bed.
A typical fluidizable bed includes a receptacle and a porous diffuser board that divides the receptacle into a plenum and a fluidizable medium container above the plenum. A quantity of a fluidizable medium, such as tiny spherical particles, occupies the fluidizable medium container. A filter sheet overlies the fluidizable medium. In operation a fluidizing medium such as ambient air is pressurized and introduced into the plenum. The air flows through the diffuser board, through the fluidizable medium, and exhausts through the filter sheet. The flow of air through the fluidizable medium imparts fluid-like properties to the fluidizable medium so that the medium acts as a quasi-fluid. Fluidizable beds are used for burn victims or other patients who have skin disorders such as pressure ulcers or who are at high risk of developing skin disorders as a result of long term confinement in bed.
Despite the advantages of fluidizable beds they do not offer other therapeutic benefits such as lateral rotation therapy. Lateral rotation therapy involves gently rotating a patient laterally left and right to help prevent pulmonary complications. Lateral rotation capability is easily incorporated in a non-fluidizable bed by providing left and right longitudinally extending, inflatable bladders beneath the occupant support mattress. In operation the left bladder is inflated by a prescribed amount to turn a supine bed occupant to his right. The left bladder is then deflated, and the right bladder is inflated to turn the occupant toward his left. The bladders may also be used in a “turn and hold” mode in which one of the bladders is inflated, maintained in its inflated state for a period of time, and then deflated without a similar inflation and deflation sequence being applied to the other bladder. This mode of operation may be used to, for example, assist a caregiver in turning a bed occupant from supine to prone or vice versa. However introducing lateral rotation bladders into a fluidizable bed, whether to carry out lateral rotation therapy, “turn and hold” or for any other reason would defeat the many benefits of using a fluidizable bed.
A fluidizable bed comprises a receptacle, a diffuser board dividing the receptacle into a plenum assembly and a fluidizable medium container, a fluidizable medium residing in the container, and a partition dividing the plenum into a first chamber adapted to receive a first stream of fluidizing medium and a second chamber adapted to receive a second stream of fluidizing medium. In operation a first stream of the fluidizing medium is admitted to the first chamber and a second stream of the fluidizing medium is admitting to the second chamber. By admitting the streams of fluidizing medium to the chambers in a phased, cyclic fashion the benefits of lateral rotation are achieved in a fluidizable bed.
The foregoing and other features of the various embodiments of the fluidizable bed described herein will become more apparent from the following detailed description and the accompanying drawings in which:
Referring to
A blower 50 is connected to the left and right chambers 34, 40 by a conduit 52 having left and right branches 54, 56. Each branch includes a flow regulating valve 60, 62. A controller 64 controls operation of the valves and blower to control admission of the fluidizing medium to chambers 34, 40. The illustration suggests the use of physical communication paths 66 from the controller to the blower and valves, however wireless communication could be used instead. A user interface 70 receives instructions for the controller from a user such as an occupant or caregiver.
Referring to
Continuing to refer to
In general the cyclic admission of fluidizing medium to the first chamber has a first upper mass flow rate amplitude corresponding to valve 60 being sufficiently open to fluidize the medium, and also has a first lower mass flow rate amplitude which is less than the first upper flow rate amplitude and corresponds to valve 60 being sufficiently closed to defluidize the medium. Similarly, cyclic admission of the fluidizing medium to the second chamber has a second upper mass flow rate amplitude and a second lower mass flow rate amplitude which is less than the second upper flow rate amplitude. At least one of the lower mass flow rate amplitudes may be zero. Typically the system will be designed so that the first and second upper mass flow rates are substantially equal to each other and the first and second lower mass flow rates are substantially equal to each other. However designs in which the first and second upper mass flow rates are not substantially equal to each other and/or the first and second lower mass flow rates are not substantially equal to each other are also contemplated.
The mode of operation described above is bilateral in that the occupant is rotated both to his left and to his right. However as seen in
In the foregoing examples the rates of admission of fluidizing material to the chambers are controlled by operating a valve. Alternatively, similar results may be achieved by regulating the performance, e.g. the operating speed, of a blower. In addition, although the examples show a single partition dividing the plenum into two chambers, a greater number of partitions dividing the plenum into a greater number of chambers could also be used.
Although this disclosure refers to specific embodiments, it will be understood by those skilled in the art that various changes in form and detail may be made without departing from the subject matter set forth in the accompanying claims.
Number | Name | Date | Kind |
---|---|---|---|
3340551 | Hopkins | Sep 1967 | A |
3485240 | Fountain | Dec 1969 | A |
3866606 | Hargest | Feb 1975 | A |
4279044 | Douglas | Jul 1981 | A |
4483029 | Paul | Nov 1984 | A |
4637083 | Goodwin | Jan 1987 | A |
5539943 | Romano | Jul 1996 | A |
5966763 | Thomas et al. | Oct 1999 | A |
6145142 | Rechin et al. | Nov 2000 | A |
6721979 | Vrzalik et al. | Apr 2004 | B1 |
7712171 | Butler | May 2010 | B2 |
20090205139 | Van Deursen et al. | Aug 2009 | A1 |
Number | Date | Country |
---|---|---|
0194868 | Sep 1986 | EP |
WO 9118578 | Dec 1991 | WO |
Number | Date | Country | |
---|---|---|---|
20140000039 A1 | Jan 2014 | US |
Number | Date | Country | |
---|---|---|---|
61665064 | Jun 2012 | US |